866-997-4948(US-Canada Toll Free)

Alzheimer’s Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Published By :

Transparency Market Research

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 175 Pages

Global Alzheimer’s Drugs Market: Overview

This report on the Alzheimer’s drugs market analyzes the current and future scenario of the global market. Increasing prevalence of Alzheimer’s, innovation in the development of new drugs, biomarker analysis and most promising molecules analysis, drug class sales during the forecast period.

Global Alzheimer’s Drugs Market: Research Methodology

The global Alzheimer’s drugs market report contain an elaborate executive summary, which includes following points such as market snapshot that provides information about various segments globally. It also comprise information and data analysis of the country’s market with respect to the segments based on drug class type, distribution channels and regions. A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section. Additionally, the section comprises PEST Analysis, Porters Five Forces Analysis and Pipeline Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global Alzheimer’s drug market.

Global Alzheimer’s Drugs Market: Segmentation

Based on drug class, the market has been segmented into four major drug class such as cholinergic, memantine, combined drugs, and others. The market segments have been analyzed based on available approved products, cost-effectiveness. All segments market size and forecast has been presented for the period from 2017 to 2025, 2016 consider as a base year for this report.

As per distribution channels, the global Alzheimer’s drugs market has been segmented into three segments including hospital pharmacy, retail pharmacy, and online sales. All market segmentations has been analyzed based on increasing demand for disease treatment. Increased patient hospitalization for the treatment of Alzheimer’s are driving the market share of hospital pharmacy segment. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also comprise the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, Alzheimer’s drugs market on the basis of region has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been presented for the period from 2015 to 2025. CAGR for all segments has been presented for the period from 2017 to 2025, 2016 consider as a base year for this report.

Global Alzheimer’s Drugs Market: Competitive Dynamics

The report also profiles major key players in the Alzheimer’s drugs market based on various attributes such as company overview, product portfolio, financial overview, business strategies, recent developments and company SWOT analysis. Major players operating in the Alzheimer’s drug market included in this report are Allergan plc, Novartis AG, Eisai Co Ltd, H Lundbeck A/S, Daiichi Sankyo Company Limited, Ono Pharmaceutical Co Ltd, Merz Holding GmbH & Co KG, and Johnson & Johnson.

Global Alzheimer’s Drugs Market is segmented as below:

Global Alzheimer’s Drug Market, by Drug Class

  • Cholinergic
  • Memantine
  • Combined Drug
  • Others

Global Alzheimer’s Drug Market, by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales

Global Alzheimer’s Drug Market, by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

 

Table of Content

Chapter 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Chapter 2 Assumptions and Research Methodology 
2.1 Assumptions
2.2 Research Methodology

Chapter 3 Executive Summary
3.1 Alzheimer’s Drugs Market Snapshot, 2016
3.2 Alzheimer’s Drugs Market: Opportunity Map

Chapter 4 Market Overview
4.1 Introduction
4.2 Global Alzheimer’s Drugs Market Size (US$ Mn) Forecast, 2015–2025
4.3 Alzheimer’s Drugs Market Outlook 
4.4 Key Industry Events

Chapter 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis 
5.2 Drivers 
5.2.1 Increasing global prevalence of Alzheimer’s 
5.2.2 Improvising regulatory scenario
5.2.3 Increasing government funding
5.2.4 Entry of novel symptomatic therapies 
5.2.5 Growing social awareness of the disease
5.3 Restraints
5.3.1 Alzheimer’s drug failure rate at 99%
5.3.2 Multifactorial etiology and complex pathophysiology of the disease
5.3.3 High level of comorbidity occurring in the elderly population
5.3.4 Expanding diagnostic capability
5.3.5 Increasing cost for Alzheimer’s drug development
5.4 Opportunities 
5.4.1 Reduce the time and risk of AD drug development through an improvement in trial design
5.4.2 Improving clinical outcomes
5.5 Trends 
5.5.1 Development of compounds acting on the main stages of the pathogenesis of the disease (disease-modifying agents
5.5.2 Focused design of multi targeted drugs acting on multiple molecular targets involved in the pathogenesis of the disease
5.6 Porter’s Five Forces Analysis
5.7 PEST Analysis 
5.8 Pipeline Analysis 
5.9 Global Prevalence & Incidence
5.10 Biomarkers Analysis 
5.11 Most Promising Molecules

Chapter 6 Alzheimer’s Drugs Market Analysis by Drug Class
6.1 Key Findings 
6.2 Introduction 
6.3 Global Alzheimer’s Drugs Market Value Share Analysis, by Drug Class 
6.4 Global Alzheimer’s Drugs Market Forecast, by Drug Class 
6.5 Global Alzheimer’s Drugs Market Analysis, by Drug Class 
6.6 Global Alzheimer’s Drugs Market Attractiveness Analysis, by Drug Class 
6.7 Key Trends

Chapter 7 Alzheimer’s Drugs Market Analysis, by Distribution Channel
7.1 Key Findings 
7.2 Introduction 
7.3 Global Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel 
7.4 Global Alzheimer’s Drugs Market Forecast, by Distribution Channel 
7.5 Global Alzheimer’s Drugs Market Analysis, by Distribution Channel 
7.6 Global Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel 
7.7 Key Trends

Chapter 8 Alzheimer’s Drugs Market Analysis by Region
8.1 Global Alzheimer’s Drugs Market Snapshot, by Country 
8.2 Global Alzheimer’s Drugs Market Value Share Analysis, by Region 
8.3 Global Alzheimer’s Drugs Market Forecast, by Region 
8.4 Global Alzheimer’s Drugs Market Attractiveness, by Region

Chapter 9 North America Alzheimer’s Drugs Market Analysis
9.1 Key Findings 
9.2 North America Alzheimer’s Drugs Market Overview 
9.3 North America Alzheimer’s Drugs Market Value Share Analysis, by Drug Class 
9.4 North America Alzheimer’s Drugs Market Forecast, by Drug Class
9.5 North America Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel 
9.6 North America Alzheimer’s Drugs Market Forecast, by Distribution Channel 
9.7 North America Alzheimer’s Drugs Market Value Share Analysis, by Country 
9.8 North America Alzheimer’s Drugs Market Forecast, by Country 
9.9 North America Alzheimer’s Drugs Market Attractiveness Analysis 
9.10 Market Trends

Chapter 10 Europe Alzheimer’s Drugs Market Analysis
10.1 Key Findings 
10.2 Europe Alzheimer’s Drugs Market Overview 
10.3 Europe Alzheimer’s Drugs Market Value Share Analysis, by Drug Class 
10.4 Europe Alzheimer’s Drugs Market Forecast, by Drug Class
10.5 Europe Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel 
10.6 Europe Alzheimer’s Drugs Market Forecast, by Distribution Channel 
10.7 Europe Alzheimer’s Drugs Market Value Share Analysis, by Country 
10.8 Europe Alzheimer’s Drugs Market Forecast, by Country 
10.9 Europe Alzheimer’s Drugs Market Attractiveness Analysis 
10.10 Market Trends

Chapter 11 Asia Pacific Alzheimer’s Drugs Market Analysis
11.1 Key Findings 
11.2 Asia Pacific Alzheimer’s Drugs Market Overview 
11.3 Asia Pacific Alzheimer’s Drugs Market Value Share Analysis, by Drug Class 
11.4 Asia Pacific Alzheimer’s Drugs Market Forecast, by Drug Class
11.5 Asia Pacific Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel 
11.6 Asia Pacific Alzheimer’s Drugs Market Forecast, by Distribution Channel 
11.7 Asia Pacific Alzheimer’s Drugs Market Value Share Analysis, by Country 
11.8 Asia Pacific Alzheimer’s Drugs Market Forecast, by Country 
11.9 Asia Pacific Alzheimer’s Drugs Market Attractiveness Analysis 
11.10 Market Trends

Chapter 12 Latin America Alzheimer’s Drugs Market Analysis
12.1 Key Findings 
12.2 Latin America Alzheimer’s Drugs Market Overview 
12.3 Latin America Alzheimer’s Drugs Market Value Share Analysis, by Drug Class 
12.4 Latin America Alzheimer’s Drugs Market Forecast, by Drug Class
12.5 Latin America Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel 
12.6 Latin America Alzheimer’s Drugs Market Forecast, by Distribution Channel 
12.7 Latin America Alzheimer’s Drugs Market Value Share Analysis, by Country 
12.8 Latin America Alzheimer’s Drugs Market Forecast, by Country 
12.9 Latin America Alzheimer’s Drugs Market Attractiveness Analysis 
12.10 Market Trends

Chapter 13 Middle East and Africa (MEA) Alzheimer’s Drugs Market Analysis
13.1 Key Findings 
13.2 Middle East and Africa Alzheimer’s Drugs Market Overview 
13.3 Middle East and Africa Alzheimer’s Drugs Market Value Share Analysis, by Drug Class 
13.4 Middle East and Africa Alzheimer’s Drugs Market Forecast, by Drug Class
13.5 Middle East and Africa Alzheimer’s Drugs Market Value Share Analysis, by Distribution Channel
13.6 Middle East and Africa Alzheimer’s Drugs Market Forecast, by Distribution Channel 
13.7 Middle East and Africa Alzheimer’s Drugs Market Value Share Analysis, by Country 
13.8 Middle East and Africa Alzheimer’s Drugs Market Forecast, by Country 
13.9 Middle East and Africa Alzheimer’s Drugs Market Attractiveness Analysis 
13.10 Market Trends

Chapter 14 Company Profiles
14.1 Alzheimer’s Market Share Analysis By Company 
14.2 Competition Matrix 
14.3 Company Profiles
14.3.1 Allergan plc
14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2 Product Portfolio
14.3.1.3 SWOT Analysis
14.3.1.4 Strategic Overview
14.3.2 Novartis AG
14.3.2.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2 Product Portfolio
14.3.2.3 SWOT Analysis
14.3.2.4 Strategic Overview
14.3.3 Eisai Co Ltd
14.3.3.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.3.4 Strategic Overview
14.3.4 Johnson & Johnson
14.3.4.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.4.4 Strategic Overview
14.3.5 Daiichi Sankyo Company Limited
14.3.5.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2 Product Portfolio
14.3.5.3 SWOT Analysis
14.3.5.4 Strategic Overview
14.3.6 Ono Pharmaceutical Co Ltd
14.3.6.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.6.4 Strategic Overview
14.3.7 H Lundbeck A/S
14.3.7.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.7.4 Strategic Overview
14.3.8 Merz Holding GmbH & Co KG
14.3.8.1 Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2 Product Portfolio
14.3.8.3 SWOT Analysis
14.3.8.4 Strategic Overview

List of Table

Table 1: Alzheimer's Drugs: Pipeline Analysis – Phase III
Table 2: Alzheimer's Drugs: Pipeline Analysis – Phase II
Table 3: Alzheimer's Drugs: Pipeline Analysis – Phase I
Table 4: Prevalence and Incidence by Global and Region 
Table 5: Prevalence by Country and Region
Table 6: Biomarker Analysis List in Alzheimer’s Drug Market
Table 7: Most Promising Molecules List
Table 8: Global Alzheimer's Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 9: Global Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 10: Global Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 11: North America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 12: North America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 13: North America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 14: Europe Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 15: Europe Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Europe Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 17: Asia Pacific Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 18: Asia Pacific Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 19: Asia Pacific Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 20: Latin America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 21: Latin America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 22: Latin America Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Middle East & Africa Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
Table 24: Middle East & Africa Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 25: Middle East & Africa Alzheimer’s Drugs Market Size (US$ Mn) Forecast, by Country, 2015–2025

List of Chart

Figure 1: Alzheimer's Drugs Market Snapshot, 2016
Figure 2: DROT Executive Summary
Figure 3: Market Share Executive Summary
Figure 4: Drug Class Revenue Share, 2016
Figure 5: Distribution Channel Revenue Share, 2016
Figure 6: Global Alzheimer's Drugs Market Size (US$ Mn) Forecast, 2015–2025
Figure 7: Market Value Share, by Drug Class (2016
Figure 8: Market Value Share, by Distribution Channel (2016)
Figure 9: Market Value Share, by Region (2016)
Figure 10: Key Industry Events 
Figure 11: Global Alzheimer's Drugs Market Value Share, by Drug Class, 2017 and 2025
Figure 12: Global Cholinergic Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 13: Global Memantine Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 14: Global Combined Drug Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 15: Global Others Drug Class Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 16: Global Alzheimer's Drugs Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 17: Global Alzheimer’s Drugs Market Value Share, by Distribution Channel, 2017 and 2025
Figure 18: Global Hospital Pharmacy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 19: Global Retail Pharmacy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 20: Global Online Sales Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Global Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 22: Global Alzheimer’s Drugs Market Value Share, by Region, 2017 and 2025
Figure 23: Global Alzheimer’s Drugs Market Attractiveness Analysis, by Region, 2017–2025
Figure 24: North America Alzheimer’s Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 25: North America Alzheimer’s Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 26: North America Alzheimer’s Drugs Market Value Share, by Drug Class, 2017 and 2025
Figure 27: North America Alzheimer’s Drugs Market Value Share, by Distribution Channel, 2017 and 2025
Figure 28: North America Alzheimer’s Drugs Market Value Share, by Country, 2017 and 2025
Figure 29: North America Alzheimer’s Drugs Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 30: North America Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 31: Europe Alzheimer’s Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 32: Europe Alzheimer’s Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 33: Europe Alzheimer’s Drugs Market Value Share, by Drug Class, 2017 and 2025
Figure 34: Europe Alzheimer's Drugs Market Value Share, by Distribution Channel, 2017 and 2025
Figure 35: Europe Alzheimer’s Drugs Market Value Share, by Country, 2017 and 2025
Figure 36: Europe Alzheimer’s Drugs Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 37: Europe Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 38: Asia Pacific Alzheimer’s Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 39: Asia Pacific Alzheimer’s Drugs Market Attractiveness Analysis, by Country, 2017-2025
Figure 40: Asia Pacific Alzheimer’s Drugs Market Value Share, by Drug Class, 2017 and 2025
Figure 41: Asia Pacific Alzheimer’s Drugs Market Value Share, by Distribution Channel, 2017 and 2025
Figure 42: Asia Pacific Alzheimer’s Drugs Market Value Share, by Country, 2017 and 2025
Figure 43: Asia Pacific Alzheimer’s Drugs Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 44: Asia Pacific Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 45: Latin America Alzheimer’s Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 46: Latin America Alzheimer’s Drugs Market Attractiveness Analysis, by Country, 2017-2025
Figure 47: Latin America Alzheimer’s Drugs Market Value Share, by Drug Class, 2017 and 2025
Figure 48: Latin America Alzheimer’s Drugs Market Value Share, by Distribution Channel, 2017 and 2025
Figure 49: Latin America Alzheimer’s Drugs Market Value Share, by Country, 2017 and 2025
Figure 50: Latin America Alzheimer’s Drugs Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 51: Latin America Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 52: Middle East & Africa Alzheimer’s Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 53: Middle East & Africa Alzheimer’s Drugs Market Attractiveness Analysis, by Country, 2017-2025
Figure 54: Middle East & Africa Alzheimer’s Drugs Market Value Share, by Drug Class, 2017 and 2025
Figure 55: Middle East & Africa Alzheimer’s Drugs Market Value Share, by Distribution Channel, 2017 and 2025
Figure 56: Middle East & Africa Alzheimer’s Drugs Market Value Share, by Country, 2017 and 2025
Figure 57: Middle East & Africa Alzheimer’s Drugs Market Attractiveness Analysis, by Drug Class, 2017–2025
Figure 58: Middle East & Africa Alzheimer’s Drugs Market Attractiveness Analysis, by Distribution Channel, 2017–2025
Figure 59: Global Alzheimer’s Market Share Analysis By Company (2016)
Figure 60: Allergan plc Breakdown of Net Sales (%), by Business Segment, 2016
Figure 61: Allergan plc Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 62: Novartis Breakdown of Net Sales, by Business segments, 2016
Figure 63: Novartis Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 64: Eisai Breakdown of Net Sales, by Region, 2016
Figure 65: Eisai Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
Figure 66: Johnson Breakdown of Net Sales, by Region, 2016
Figure 67: Johnson Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
Figure 68: Daiichi Breakdown of Net Sales, by Region, 2016
Figure 69: Daiichi Revenue (US$; Mn) & Y-o-Y Growth (%), 2013–2016
Figure 70: Ono Breakdown of Net Sales, by Region, 2016
Figure 71: Ono Revenue (US$; Mn) & Y-o-Y Growth (%), 2013–2016
Figure 72: Lundbeck Breakdown of Net Sales, by Region 2016
Figure 73: Lundbeck Revenue (US$; Mn) & Y-o-Y Growth (%), 2013–2016
Figure 74: Merz Breakdown of Net Sales, by Region 2016
Figure 75: Merz Revenue (US$; Mn) & Y-o-Y Growth (%), 2013–2016

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *